Optical technologies and molecular imaging for cervical neoplasia: a program project update

Timon P. H. Buys, Scott B. Cantor, Martial Guillaud, Karen Adler-Storthz, Dennis D. Cox, Clement Okolo, Oyedunni Arulogon, Oladimeji Oladepo, Karen Basen-Engquist, Eileen Shinn, Jose-Miguel Yamal, J. Robert Beck, Michael E. Scheurer, Dirk van Niekerk, Anais Malpica, Jasenka Matisic, Gregg Staerkel, Edward Neely Atkinson, Luc Bidaut, Pierre LaneJ. Lou Benedet, Dianne Miller, Tom Ehlen, Roderick Price, Isaac F. Adewole, Calum MacAulay, Michele Follen

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)


    There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.
    Original languageEnglish
    JournalGender Medicine
    Issue number1 SUPPL.
    Publication statusPublished - 1 Feb 2012


    Dive into the research topics of 'Optical technologies and molecular imaging for cervical neoplasia: a program project update'. Together they form a unique fingerprint.

    Cite this